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On the basis of genome nucleotide differences between a nonneuropathogenic and a neuropathogenic lactate dehydro-
genase-elevating virus (LDV) quasispecies (LDV-P and LDV-C, respectively), we have designed sets of primers for polymerase
chain reaction (PCR) amplification that can detect recombinants between them in a 1276-nt-long segment ranging from ORF
5 to ORF 7. Mice were infected with large amounts of both LDVs and bled at various times postinfection (p.i.). RNA was
extracted from plasma samples and reverse transcribed and the first-strand products were PCR amplified with four sets of
sense and antisense primers that discriminate between parental (P/P and C/C) and recombinant (P/C and C/P) genomic
segments. Both P/C and C/P recombinants were detected in plasma from six different mice at 1 day p.i. No recombinant
products were generated with in vitro mixtures of LDV-P and LDV-C. End-point dilution experiments indicated that the
generation of P/C and C/P recombinants varied between mice but that in some mice the frequency of recombination in the
1276-nt-long genome segment was as high as 5%. Sequence analyses of clones of some recombinants indicated that
recombination had occurred at 26- to 43-nt-long stretches of homology between the LDV-P and the LDV-C genomes.
Sequence analyses of the 3157-nt-long 39 end of the genomes of the neuropathogenic LDV-v and of a newly discovered
nonneuropathogenic quasispecies, LDV-vx, showed that LDV-v is a natural recombinant of LDV-vx that has specifically
acquired by a double recombination about 400 nt of the 59 end of ORF 5 of the neuropathogenic LDV-C and thereby the unique
properties of LDV-C, neuropathogenicity and high sensitivity to antibody neutralization. In dual infections of mice with LDV-P
and LDV-C all genetic recombinants, like the LDV-C parent itself, had been lost by 7 days p.i., and only LDV-P persisted. The
results further support the view that LDV-P and LDV-vx have evolved to a highly stable relationship with their host, the mouse.
© 1999 Academic Press
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Genetic recombination, probably via a copy choice
echanism, has been reported for a number of positive-
tranded RNA viruses (Lai, 1992) but occurs with espe-
ially high frequency in coronaviruses (about 25% for the
ntire 32-kb genome of mouse hepatitis virus (MHV)),
erhaps because the synthesis of their 39 nested sets of
ubgenomic mRNAs most likely involves a replicase
umping step (Baric et al., 1990; Lai, 1992; Lai and Ca-
anagh, 1997). The present study demonstrates that ge-
etic recombination occurs with similar high frequency
n mice infected with the arterivirus, lactate dehydroge-
ase-elevating virus (LDV). This finding further supports
he placing of the Coronaviridae and Arteriviridae in a
ommon order, Nidovirales (Cavanagh, 1997).
Genetic recombination was demonstrated to occur
uring dual infection of mice with two LDV quasispecies,
DV-P and LDV-C, in a 1276-nt-long segment ranging
rom ORF 5 to ORF 7. These LDVs differ in several
henotypic properties. LDV-P invariably establishes an
symptomatic, life-long viremic persistent infection in
ice, which is maintained by continuous rounds of cy-t1 To whom reprint requests should be addressed.
73ocidal replication in a renewable subpopulation of mac-
ophages and its escape from all host immune re-
ponses (Plagemann et al., 1995; Chen et al., 1999). In
ontrast, LDV-C is highly sensitive to antibody neutral-
zation and therefore impaired in its ability to establish a
iremic persistent infection, but is neuropathogenic for
mmunosuppressed C58 or AKR mice (Chen et al., 1997,
998, 1999). These differences in phenotypic properties
ave been linked to differences in the short (about 30-
mino-acid-long) ectodomain of the primary envelope
lycoprotein VP-3P encoded by ORF 5 (Chen et al., 1998,
999), which contains the neutralization epitope of all
DVs (Li et al., 1997) and is involved in host–receptor
nteraction (Faaberg et al., 1995; Faaberg and Plage-
ann, 1995). The complete genomes of LDV-C and
DV-P have been sequenced (Godeny et al., 1993;
almer et al., 1995). They diverge by about 20%. We also
eport the sequences of the 39 ends encompassing ORFs
–7 (3157 nt) of the genomes of another recently discov-
red nonneuropathogenic LDV quasispecies, LDV-vx,
nd of another neuropathogenic LDV, LDV-v (Chen et al.,
998), and demonstrate that LDV-v is a natural recombi-
ant between LDV-vx and LDV-C that has specifically
cquired the segment of ORF 5 of LDV-C that encodeshe ectodomain of VP-3P.
0042-6822/99 $30.00
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74 LI, CHEN, AND PLAGEMANNRESULTS
enetic recombination between nonneuropathogenic
DV-P and neuropathogenic LDV-C in mice
For exploring the occurrence of genetic recombination
n LDV infections we have developed a reverse transcrip-
ion–polymerase chain reaction (RT-PCR) method that
FIG. 1. Comparisons of the 39 ends of the LDV-P and LDV-C genome
DV-C are from Palmer et al. (1995; GenBank Accession No. U15146)
ecombinants were generated as described in the legend to Fig. 2 and
els, purified, and cloned and the clones were sequenced as describe
he segments where the 59 leader becomes joined to the bodies of mRN
nd LDV-C occurred are shown in boxes. The primers used for the d
ecombinants as well as the antisense primers used in the different
espectively; see Fig. 7A; Chen et al., 1998) are overlined or underlined
ense, respectively.an detect recombinants between the LDV-C and the (DV-P genomes in their 39 ends. For the design of LDV
uasispecies-specific sense and antisense primers we
elected 20-nt-long segments in ORF 5 (J1026/ and
1027/) and ORF 7 (/J1028 and /J1029), respectively, that
iffered by 5 or 7 nucleotides between LDV-P and LDV-C
see Fig. 1). These primers were highly specific for LDV-P
nd LDV-C since PCR products of the appropriate size
f genetic recombinants between them. The sequences for LDV-P and
deny et al. (1993; GenBank Accession No. L13298), respectively. The
text. PCR products of the recombinants were extracted from agarose
r Materials and Methods. The initiation codons for ORFs 6 and 7 and
d 7 are overlined. The segments where recombination between LDV-P
tial PCR amplification of the LDV-P and LDV-C genomes and of the
CR assay for distinguishing LDV-P and LDV-C/v (/J1004 and /J1003,
lashes before and after the primer designation indicate antisense ands and o
and Go
in the
d unde
A 6 an
ifferen
ial RT-P
. The s1276 bp) were obtained only with the P-specific and
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75RECOMBINATION OF LACTATE DEHYDROGENASE-ELEVATING VIRUS-specific sense and antisense primers, respectively
Fig. 2, sets 1 and 2). The potential generation of genetic
ecombinants was investigated in mice, because no cell
ine that supports LDV replication in vitro has been found
Plagemann, 1996). Two FVB mice were infected intra-
eritoneally (ip) with high concentrations of both cloned
DV-P and LDV-C (about 108 ID50/mouse) in order to
nfect as many of the approximately 106 LDV permissive
acrophages/mouse (Plagemann, 1996) as possible
ith both LDVs. The mice were bled 1 day later, and total
NA was extracted from their plasma and reverse tran-
cribed. The first-strand products were then subjected to
CR with the primer sets J1026/J1028 (P/P-specific),
1027/J1029 (C/C-specific), J1026/J1029 (P/C-specific),
nd J1027/J1028 (C/P-specific; Fig. 1). As indicated in Fig.
, genetic recombinant RNAs were detected in total RNA
btained from plasma of the two dually infected mice; in
ne mouse both P/C and C/P recombinants were de-
ected (set 4), whereas in the other mouse only C/P
ecombinants were detected (set 6). In contrast, no re-
ombinant PCR products were generated from in vitro
ixtures of LDV-C and LDV-P (sets 3 and 5). Thus recom-
inants were generated only during mixed infections of
ice with LDV-C and LDV-P and were not generated
uring the reverse transcription or PCRs. The extracted
ecombinant RNA was probably located in virions since
he RNA was extracted from plasma, which is unlikely to
ontain significant amounts of free viral RNA released
rom lysed macrophages (the plasma contained 109.5
D50 of virus/ml).
The three recombinant PCR products were isolated
rom the agarose gel, purified, and TA cloned and one
lone of each was sequenced. The sequence analyses
onfirmed that the expected recombinations had oc-
urred and identified the locations of the recombinations.
ecombination in the C/P-2 recombinant had occurred in
FIG. 2. Generation of genetic recombinants by dual infection of m
ndependent experiments with approximately 108 ID50 of both LDV-P an
lasma samples and reverse transcribed. The first-strand products wer
ig. 1): J1026/J1028 (P/P), J1027/J1029 (C/C), J1026/J1029 (P/C), and J102
DV-C (sets 1 and 2, respectively) and from in vitro mixtures of clonedrelatively long homologous stretch (43 bp) in the 39 end tf ORF 5 (Fig. 1). On the other hand, recombination in the
/P-1 recombinant and the P/C-1 recombinant had oc-
urred in a shorter homologous segment (26 bp) in ORF
with long A and T stretches (Fig. 1). Since reciprocal
ecombinants (C/P and P/C) were obtained in this seg-
ent it may represent a hot spot for recombination per-
aps because of the presence of the A and T stretches
Fig. 1). Another possibility is that these recombinant
NAs became selectively incorporated into virions. Se-
ective replication of certain recombinants cannot have
layed a role, since practically all permissive macro-
hages in the mice probably became initially infected at
he high inoculation doses and most of the 1-day virus
arvest therefore resulted from a single cycle of replica-
ion (Plagemann, 1996). No other unusual nucleotide
rrangements were discernible in the recombination
egments and they did not contain any sequence where
he leader is joined to the bodies of the mRNAs (Fig. 1).
It has been postulated that the copy choice type of
ecombination may involve pausing and detachment of
he replicase-partial product complex at regions with
econdary structure (Lai, 1992). However, we have not
etected any characteristic secondary structure loops in
ssociation with the segments where genetic recombi-
ation occurred (data not shown). Earlier results had
hown that LDV-P genomic RNA in solution possesses
onsiderable secondary structure similar to that of ribo-
omal RNAs (Brinton-Darnell and Plagemann, 1975).
econdary structure analyses of genomic RNA segments
y the method of Zucker using the MFold program
Zucker and Stiegler, 1981) confirmed this conclusion but
ielded very variable patterns of hybridization depending
n the size of the RNA analyzed. Analysis of LDV mRNA
, which contains ORFs 6 and 7, indicated over 50%
econdary structure (exclusive of the 59 leader and the 39
oly(A) tail). The segment where reciprocal recombina-
h cloned LDV-P and cloned LDV-C. Four mice were infected in two
-C and 1 day later plasma was obtained. RNA was extracted from the
fied by PCR using four sets of LDV-P- and LDV-C-specific primers (see
(C/P; sets 4 and 6–8). RNA was also isolated from cloned LDV-P and
and LDV-C (sets 3 and 5) and analyzed in the same manner.ice wit
d LDV
e ampli
7/J1028ion had occurred in ORF 6 (see Fig. 1) was part of a long
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76 LI, CHEN, AND PLAGEMANNtretch that was potentially partially hybridized to a dis-
ant segment upstream in ORF 6, but similar hybridiza-
ions were predicted throughout ORF 6 and ORF 7 (data
ot shown).
The frequency of the in vivo genetic recombination
as investigated in several ways. First, we compared the
elative recovery of recombinant PCR products gener-
ted with RNA extracted from the plasma of several
dditional mice that had been dually infected with LDV-P
nd LDV-C for 1 day. In these experiments we found that
n several dually infected mice both P/C and C/P recom-
inant PCR products were generated in amounts that
pproached those of the parent PCR products (e.g., Fig.
, sets 7 and 8). However, the recovery of recombinant
CR products from different dually infected mice varied
ith respect to total quantity and the relative amounts of
ach. This variation was probably due to variations in the
n vivo infections of permissive macrophages by both
arents and not to technical factors since similar results
ere obtained when the same plasma samples of the
ually infected mice were repeatedly analyzed (see be-
ow; and data not shown).
Second, we explored the time courses of PCR ampli-
ication of the first-strand cDNAs of the parent and re-
ombinant RNAs. RNA extracted from the plasma of a
-day LDV-P and LDV-C dually infected mouse (Fig. 2, set
) was reverse transcribed and samples of the first-
trand cDNA were amplified by PCR with different cycles.
our PCRs were run with the primer pairs P/P, C/C, P/C,
nd C/P, and samples thereof were run for 24, 26, 28, 30,
2, 34, 36, and 38 cycles. The PCR products were elec-
rophoresed and examples (every fourth cycle from 26 to
8) are shown in Fig. 3B. The total density of each gel
and was measured with an Alpha Imager (AlphaInno-
ech Corp., San Leandro, CA) and the integrated density
alues (IDV) are plotted as a function of the number of
CR cycles in Fig. 3A. The results indicate that the
eneration of PCR products of the two parent LDVs was
pproaching a maximum. The PCR products of the two
ecombinants were clearly present in lower concentra-
ions. Although the proportion of first-strand cDNAs be-
ween the recombinants and their parents cannot be
ccurately estimated from the data because they do not
llow extrapolation of the curves to zero cycle, a rough
stimate is possible. In another similar experiment faint
CR product bands comparable to those observed for
he P/C recombinant after 26 cycles and the C/P recom-
inant after 30 cycles were obtained for the parent LDV-C
fter 20 cycles, whereas no products were detectable at
0 cycles (data not shown). Thus, combined the data
uggest that the first-strand cDNA of the P/C recombi-
ants may have represented 1–2% and that of the C/P
ecombinant 0.1% of those of the parent LDVs. These
stimates are based on the assumption that the first-
trand cDNAs of the parents and recombinants were
CR amplified with similar efficiencies using their re-pective primer sets and that the amounts of PCR prod-
ct generated doubled for every cycle at least up to
ntegrated density values of 1000. These assumptions
eem justified by the similar shapes of the “dose–
esponse” curves for the four primer sets (Fig. 3A and
ee Fig. 3C).
Results similar to those described above were ob-
ained in another experiment of this type in which we
ttempted to equalize the PCR amplification of the re-
ombinant and parent RNAs. RNA was extracted from
ndiluted plasma of a dually infected mouse (see Fig. 2,
et 7) and reverse transcribed and samples of the first-
trand product were amplified for 26, 30, 34, and 38
ycles using the P/C and C/P primer sets. PCR amplifi-
ation was conducted in duplicate for each cycle in order
o demonstrate the reproducibility of the PCR amplifica-
ion (Fig. 3D). Average integrated density values for these
ands are plotted in Fig. 3C as a function of the PCR
ycle. We also extracted RNA from 1:10, 1:40, 1:80, and
:160 dilutions of plasma of this dually infected mouse
nd analyzed the RNA samples in the same manner,
xcept that PCR amplification was conducted with the
/P primer set (Fig. 3C). The results show that the curves
or the P/C and C/P recombinants fell between those for
he P/P parent obtained with RNA from the 1:10 and 1:40
lasma dilutions. No P/P PCR products became gener-
ted in 38 cycles with RNA from the 1:160 plasma dilution
data not shown). The results indicate that both recom-
inant RNAs were present in the plasma at levels be-
ween 2.5 and 10% of that of the LDV-P parent. This
onclusion is based on the assumption that the RNAs of
he parent and recombinants are reverse transcribed
ith similar efficiency. A repeat of this experiment using
lasma from the same dually infected mouse yielded
ery similar results (data not shown).
The third approach consisted of conventional end-
oint dilution RT-PCR analyses (Chen et al., 1997). RNA
as extracted from 10-fold dilutions of plasma from a
-day dually infected mouse that contained primarily C/P
ecombinants (see below and Fig. 6, set 3). Each sample
as reverse transcribed and the first-strand cDNAs were
mplified by PCR (38 cycles) using the four sets of
rimers described already (Fig. 4A). The densities of the
CR product bands indicated that the decrease in PCR
roduct formation with a decrease in the amount of
lasma from which RNA was extracted was only slightly
ore rapid for the C/P recombinant than the P/P parent,
ut that the C/C parent was still detectable at a 10-fold
igher dilution. The results suggest that the C/P recom-
inant RNA was present in the plasma at about 10 and
% of the levels of RNA of the P/P and C/C parents,
espectively. The P/C recombinant was detected only in
ndiluted plasma (see below and Fig. 6, set 3) and
herefore estimated to be present at 0.5% of the level of
he P/P parent.Similar results were obtained in another end-point
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77RECOMBINATION OF LACTATE DEHYDROGENASE-ELEVATING VIRUSilution RT-PCR experiment using plasma from another
ually infected mouse (see Fig. 2, set 7). RNA was ex-
racted from fivefold dilutions of the plasma, the RNA
amples were reverse transcribed, and the first-strand
DNAs were amplified by PCR (40 cycles) using the four
ense and antisense primer sets. The densities of the
ndividual PCR bands indicated that in this case LDV-C
NA was present in the plasma at an approximately 25
imes higher level than the LDV-P RNA (Fig. 4B) and that
he P/C and C/P recombinant RNAs represented about 4
nd 0.2% of the LDV-P and LDV-C RNAs, respectively
Fig. 4B). Comparable results were obtained in a repeat
nalysis of the plasma of this dually infected mouse
data now shown). The data also agree with those in Fig.
C for the same dually infected mouse. The higher yield
f LDV-C than LDV-P RNA could suggest that in this
FIG. 3. Quantitation of PCR products amplified from first-strand produ
CR cycle. In (A/B), RNA was extracted from 4 ml of plasma of a 1-day d
f the first-strand cDNA were amplified in 2 cycle intervals (24–38 cy
lectrophoresed and the densities of the product bands (for example, s
s a function of the PCR cycle in A. In (C/D), RNA was extracted from un
:40, 1:80, and 1:160 dilutions thereof. The first-strand cDNAs derived fr
rimer pairs for 26, 30, 34, and 38 cycles. The PCR products were elec
y integrated image analysis and their averages are plotted as a func
ilutions were similarly PCR amplified using the P/P primer set. No P/
hown).ouse a considerable number of macrophages became nnfected with LDV-C but not LDV-P. This conclusion is
uggested by the finding that the yield of LDV-P and
DV-C/macrophage in independent infections is very
imilar (Chen et al., 1997, 1998, 1999), but whether this
inding applies to dually infected mice is not known. If it
oes apply, the yield of LDV-P may better reflect the LDV
ield from dually infected macrophages than the LDV-C
ield and provide a more accurate basis for calculation of
he recombination frequency.
DV-v is a natural genetic recombinant of the
onneuropathogenic LDV-vx that has specifically
cquired the VP-3P ectodomain of LDV-C
Our original neuropathogenic isolate, LDV-VIR (Ander-
on et al., 1995a), was found to consist of three LDVs, the
recombinant and parent RNAs of dually infected mice as a function of
fected mouse (see Fig. 2, set 4) and reverse transcribed and samples
ing the P/P, C/C, P/C, and C/P primer sets. The PCR products were
ere measured by integrated image analysis (see text) and are plotted
plasma of another dually infected mouse (Fig. 2, set 7) and from 1:10,
iluted plasma were PCR amplified in duplicate using the P/C and C/P
resed and the densities of the product bands (see D) were measured
the PCR cycle in C. The first-strand cDNAs derived from the plasma
ucts were generated from the 1:160 plasma dilution in 38 cycles (notcts of
ually in
cles) us
ee B) w
diluted
om und
tropho
tion of
P prodeuropathogenic LDV-v and two nonneuropathogenic
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78 LI, CHEN, AND PLAGEMANNDVs, LDV-P and a new quasispecies, designated
DV-vx (Chen et al., 1998). LDV-v and LDV-vx have been
iologically cloned from LDV-VIR (Chen et al., 1998) and
he 3157-nt-long 39 ends encompassing ORFs 2–7 of
heir genomes have been sequenced (Fig. 5). The results
ndicated that, except for an approximately 400-nt-long
egment in the 59 end of ORF 5, the segment of LDV-v
as close to identical to that of LDV-vx; in fact, only 26 nt
f a total of about 2750 nt in the segments upstream and
ownstream of the 400-nt-long ORF 5 divergent segment
FIG. 5. Comparison of the nucleotide sequences of 3157-nucleotide
he 39 end of ORF 1b to ORF 7. The LDV-C sequence is from Godeny et
nd LDV-vx (GenBank Accession Nos. AF092282 and AF092283, respec
lones. One set of clones (1728 nucleotides long) was generated by
epresenting a segment upstream of ORF 2 in ORF 1b (A1509/; Chen et
or LDV-vx, underlined; and /J1003 for LDV-v, overlined; Chen et al., 199
y PCR amplification of first-strand cDNA using sense and antisense pr
993, 1998; see figure). These primers were selected because they rep
t al., 1995). The initiation codons of ORFs 2–7 and segments where the
re overlined, the termination codons of the ORFs are underlined, and th
ssay for distinguishing LDV-C and LDV-v/vx genomes (see Fig. 7B) are
FIG. 4. End-point dilution analyses of recombinant and parent RNAs f
rom 10-fold dilutions of plasma from a 1-day dually infected mouse (see
y PCR (38 cycles) with the P/P, C/C, P/C, and C/P primer sets and the
xperiment using plasma from another dually infected mouse (Fig. 2,DV-C and LDV-vx occurred are shown in boxes.iffered (,1%). The latter segment in the 59 end of ORF
, on the other hand, was clearly derived from the LDV-C
enome, apparently by a double homologous genetic
ecombination (Fig. 5). This segment of LDV-C acquired
y LDV-v encodes the signal peptide, the ectodomain,
nd the putative transmembrane segments of VP-3P.
ince the signal peptide of VP-3P is removed during
embrane-associated synthesis (Faaberg and Plage-
ann, 1995) and the transmembrane segments do not
ossess any amino acid differences that correlate with
egments of the genomes of LDV-C, LDV-v, and LDV-vx encompassing
3) as corrected in ORF 2 by Chen et al. (1998). The sequences of LDV-v
ere obtained by sequencing three overlapping sets of PCR generated
mplification of the first-strand cDNA using a common sense primer
8) in combination with antisense primers in the 59 end of ORF 5 (/J1007
other sets of clones (688 and 1079 nucleotides long) were obtained
ts A1468/B1836 and J1005/B1151 (overlined), respectively (Chen et al.,
segments that are identical in the LDV-P and LDV-C genomes (Palmer
der is joined to the bodies of the respective mRNAs (Chen et al., 1993)
and antisense oligonucleotide primers used in the differential RT-PCR
overlined or underlined. The segments where recombination between
ally infected mice using RT-PCR for detection. In A, RNA was extracted
, set 3) and reverse transcribed. The first-strand cDNAs were amplified
cts were electrophoresed. The results in B are from a similar dilution-long s
al. (199
tively) w
PCR a
al., 199
8). The
imer se
resent
59 lea
e sense
eitherrom du
Fig. 6
produ
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80 LI, CHEN, AND PLAGEMANNhe phenotypic properties of the two types of LDV (Chen
t al., 1998), the molecular determinants of both neuro-
athogenicity and sensitivity to antibody neutralization
haracteristic of LDV-C and LDV-v must be located in the
P-3P ectodomain (see below).
Homologous genetic recombination between LDV-C
nd LDV-vx had occurred just upstream of ORF 5 and in
he middle of ORF 5 at long stretches of homology (Fig.
). No characteristic features were apparent in the seg-
ents where the homologous recombinations had oc-
urred, except that recombination occurred within rela-
ively long stretches of homology between the LDV-C and
he LDV-vx genomes. In addition the upstream recombi-
ation occurred in a segment containing the site where
he 59 leader becomes attached to the body of the VP-3P
RNA (Fig. 5, overlined). Thus this recombination could
ave occurred during synthesis of the subgenomic
RNA.
FIG. 6. Fate of recombinants between LDV-P and LDV-C in mixed
nfection with LDV-P and LDV-C. Two FVB mice were infected with 108
D50 of both cloned LDV-P and LDV-C. Plasma was harvested at 1, 4, 7,
nd 16 days p.i. RNA was extracted from plasma samples and reverse
ranscribed and the first-strand products were amplified by PCR using
he four sets of LDV-P- and LDV-C-specific primers as described in the
egend to Fig. 1 (sets 2–6). RNA was also isolated from an in vitro
ixture of cloned LDV-P and LDV-C and analyzed in the same manner
set 1).
FIG. 7. Competition between LDV-P and LDV-v (A) and between LDV-
loned LDV-P and LDV-v (A) or cloned LDV-v and LDV-C (B). In (B), the m
5 days p.i. The mice of both groups were bled at intervals and their p
l., 1997, 1998). In (A), first-strand products were PCR amplified using a
hen et al., 1998) plus LDV-P-specific and LDV-C/v-specific antisense p
f 483 bp). In (B), the first-strand products were PCR amplified using th
/J1031 and /J1030, respectively; see Fig. 5; PCR product of 587 bp). The
or the second mouse (data not shown).DV-P rapidly outcompetes all genetic recombinants
s well as the neuropathogenic LDVs
In the following experiment we have explored the
bility of the LDV-C/P and LDV-P/C recombinants to com-
ete with LDV-P in infected mice. Two FVB mice (H and
) were infected as already described with 108 ID50 of
oth cloned LDV-C and cloned LDV-P. RNA was extracted
rom plasma samples taken at 1, 4, 7, and 16 days p.i. and
nalyzed by the differential RT-PCR assay using the four
ombinations of the LDV-P- and LDV-C-specific sense
nd antisense primers (see Fig. 1). The results in Fig. 6
emonstrate that 1 day p.i. P/C recombinant RNA was
resent in the H mouse (set 2) and both P/C and C/P
ecombinant RNAs in the T mouse (set 3). Again, no P/C
r C/P recombinant products were generated when
DV-P and LDV-C were mixed in vitro (set 1). For the
T-PCR analyses of the later time points the RNAs iso-
ated from the plasma of the two mice were pooled. The
esults show that by 4 days p.i. both types of recombi-
ants were still present but at much reduced concentra-
ions, just as observed for LDV-C (set 4), but that by 7
ays p.i. LDV-P was the only LDV remaining (set 5). Thus
ll recombinants, like the parent LDV-C, were rapidly
utcompeted by LDV-P.
That the neuropathogenic LDV-C is rapidly outcom-
eted by LDV-P has been reported previously (Chen et
l., 1997). Similarly, Fig. 7A shows that after a mixed
nfection of a mouse with cloned LDV-P and LDV-v the
enomes of both were present in similar amounts in
lasma at 1 day p.i. but that by 8 days p.i. LDV-v was
resent in a greatly reduced amount and that by 15 days
.i. it had been lost entirely. Similar results were obtained
n a second companion mouse (data not shown). LDV-C
nd LDV-v were similarly rapidly outcompeted in mixed
nfections by LDV-vx (Chen et al., 1998). Furthermore,
oth were outcompeted by LDV-P and LDV-vx even in
DV-C (B). Groups of two FVB mice were infected with 106 ID50 of both
re injected with cyclophosphamide (20 mg/kg body weight) at 1, 8, and
was assayed by differential RT-PCR as described previously (Chen et
primer representing a common segment in ORF 4 (J1008/, see Fig. 5;
/J1004 and /J1003, respectively; see Figs. 1 and 5, ORF 5; PCR product
e primer A1468/ with LDV-v/vx- and LDV-C-specific antisense primers
shown are for one mouse in each group. Similar results were obtainedv and L
ice we
lasma
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e sens
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81RECOMBINATION OF LACTATE DEHYDROGENASE-ELEVATING VIRUSice that are unable to mount anti-LDV immune re-
ponses, such as in nude and SCID BALB/c mice (un-
ublished data). Thus the loss of LDV-C and LDV-v in
ixed infections with LDV-P/vx is not simply due to
ntibody neutralization, as is their inability to establish a
igh viremic persistent infection, but rather to an intrinsic
eplication disadvantage. This finding is pertinent for
nderstanding the evolution and selection of the neuro-
athogenic LDV-v, the genetic recombinant between
DV-vx and LDV-C. LDV-C itself probably evolved from
DV-P, LDV-vx, or some other nonneuropathogenic LDV
uring repeated long-term passages in immunosup-
ressed C58 mice because its ability to productively
nfect the anterior horn neurons of these mice provided a
elective advantage under these conditions. Its infection
f anterior horn neurons in immunosuppressed C58
ice that results in paralytic disease occurs primarily
etween 2 and 3 weeks p.i. (Anderson et al., 1995b) and
epresents a primary source of progeny LDV at a time
hen its replication in the periphery is limited to newly
enerated permissive macrophages (Plagemann and
oennig, 1982; Plagemann, 1996). The recombinant
DV-v most likely became selected during passages in
58 mice because of an enhanced ability, derived from
DV-vx, to productively infect permissive macrophages,
hile possessing the ability of LDV-C to infect the ante-
ior horn neurons of the C58 mice. This conclusion is
uggested by the finding that during a mixed infection of
n FVB mouse LDV-v outcompeted LDV-C (Fig. 7B),
hough more slowly than it itself was outcompeted by
DV-P (Fig. 7A). Similar results were obtained with a
econd companion mouse (data not shown). This differ-
nce between LDV-v and LDV-C was clearly unrelated to
ntibody neutralization since the mice had been immu-
osuppressed by repeated injections of cyclophospha-
ide and, in any case, they exhibit similar sensitivity to
ntibody neutralization (Chen et al., 1999).
For specifically distinguishing the genomes of LDV-C
nd LDV-v (Fig. 7B) we designed a new set of antisense
rimers to segments in the 39 end of ORF 5 that differ by
5% for LDV-C and LDV-v (/J1030 and /J1031, respectively;
ee Fig. 5). However, this segment is identical for LDV-v
nd LDV-vx (Fig. 5), so that the PCR assay does not
istinguish between the genomes of these LDVs.
DISCUSSION
Our data demonstrate that homologous recombination
etween LDV-P and LDV-C occurs reproducibly when
ice are dually infected with high doses of the two
iruses. Recombinants were generated in all six dually
nfected FVB mice, in general of both the P/C and the C/P
ypes. Where investigated, recombination had occurred
t long stretches of homology, but no other consistent
pecific feature was detectable at the recombination
ites. The recovery of recombinants varied somewhat brom mouse to mouse, probably because it is unlikely
hat all permissive macrophages in a mouse became
ually infected, a prerequisite for the generation of re-
ombinants, and the proportion that became dually in-
ected probably varied between mice. This problem also
ust have resulted in an underestimation of the mea-
ured apparent frequencies of recombination. Neverthe-
ess, combined the data depicted in Fig. 3 and 4 indicate
hat in some mice the amounts of recombinant RNA
enerated in the 1276-nt-long 39 end of the LDV genome
epresented at least 5% of the parent RNAs (this calcu-
ation is based on the assumption that the efficiency of
everse transcription of the parent and recombinant
NAs was similar, which seems likely). Thus the fre-
uency of recombination for LDV seems to be quite high.
n fact, it seems to be as high or higher than that reported
or MHV for a similar size segment of the genome (1% per
300 nt; Baric et al., 1990; Lai, 1992). These recombina-
ion frequencies are underestimations, because double
ross-overs, which occur with relatively high frequency
n coronaviruses (Baric et al., 1990) and which we have
emonstrated for LDV-v (Fig. 5), were not scored. Also,
he recombination frequencies are much higher for the
ntire genome since the frequency of recombination is
roportional to the distance between recombination
ites (Lai, 1992). Although we have examined genetic
ecombination only over a 1276-nt-long segment in the 39
nd of the LDV genome, experiences with other positive-
tranded RNA viruses suggest that genetic recombina-
ion generally occurs with similar frequency in all seg-
ents of the genome (Baric et al., 1990; Lai, 1992). A high
requency of genetic recombination is probably a com-
on property of arteriviruses, since recent studies indi-
ate that it also occurs during infections of pigs and cell
ulture with another arterivirus, porcine reproductive and
espiratory syndrome virus (Faaberg, personal commu-
ication).
Genetic recombination probably does not play a sig-
ificant role in the evolution of LDV in mice at present,
ecause the prominent LDV quasispecies in nature,
DV-P and LDV-vx, which are closely related (94.3% nt
dentity in the 3157-nt-long 39 end), have attained optimal
roperties for replication and survival in nature. They
eem to have become selected for optimum ability to
roductively infect the macrophages of the permissive
ubpopulation and for high resistance to all host immune
esponses, which allows them to establish life-long vire-
ic persistent infections in inbred mouse strains derived
rom Mus musculus (Chen et al., 1998, 1999). Their ge-
omes appear extremely stable in these mice. For ex-
mple, we found that ORF 5 was almost identical in
DV-P and LDV-vx-like LDVs present in LDV populations
riginally isolated from mice carrying different trans-
lantable tumors at least 12 years apart (LDV-RIL, LDV-
LA, LDV-VIR) and despite the fact that the LDVs had
een passaged numerous times in different mouse
s
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82 LI, CHEN, AND PLAGEMANNtrains (Chen et al., 1998 and unpublished data). Simi-
arly, .99% nucleotide identity was observed in ORF 5 of
he parent LDV-vx and multiple clones of LDV-vx isolated
rom both nude and wild-type BALB/c mice 100 days p.i.
Chen et al., 1999). The results indicate that practically all
utants that are expected to arise with high frequency
Holland et al., 1992) possess a replication disadvantage
nd are rapidly outcompeted by LDV-P and LDV-vx. Ex-
mples supporting this view are provided by the rapid
oss of neuropathogenic LDV-C and LDV-v during mixed
nfections with LDV-P and LDV-vx (Chen et al., 1998, 1999,
nd see Fig. 7A) as well as of a number of neutralization
scape variants isolated from them (unpublished data)
nd the genetic recombinants between LDV-P and LDV-C
Fig. 6).
Recent experiments have indicated that the resistance
f LDV-P and LDV-vx and closely related LDVs to the
umoral immune response is due to the association of
hree large polylactosaminoglycan chains with the neu-
ralization epitope on the ectodomain of VP-3P that im-
air the immunogenicity of the epitope and renders
hese LDVs largely resistant to antibody neutralization
Chen et al., 1999; Plagemann et al., in press). The VP-3P
ctodomain of the neuropathogenic LDV-C lacks the two
-terminal polylactosaminoglycan chains, which renders
he neutralization epitope more immunogenic and LDV-C
ensitive to antibody neutralization (Chen et al., 1999).
owever, these changes in the neutralization epitope
ere probably coincidental and immaterial in the evolu-
ion of LDV-C during the long-term passages in immuno-
uppressed C58 mice. The positive selective pressure
as probably for amino acid changes that allow LDV-C to
roductively infect the anterior horn neurons of C58 mice
ia recognition of an alternate receptor on these cells
Chen et al., 1998). The accompanying alterations in the
eutralization epitope were tolerated because selection
ccurred in immunosuppressed mice.
LDV-v, the recombinant of LDV-vx that has specifically
cquired by a double recombination the genome seg-
ent of LDV-C that encodes the short ectodomain of
P-3P, apparently became selected because it inherited
he ability of LDV-C to infect the anterior horn neurons of
58 mice, while retaining the slight advantage of LDV-vx
ver LDV-C in replicating in macrophages (Fig. 7B). The
lightly reduced ability of the neuropathogenic LDV-C
nd LDV-v to compete with LDV-P and LDV-vx in mixed
nfections of macrophages also probably developed in-
identally during the selection of LDV-C. The molecular
eterminants of the replication disadvantages of these
europathogenic LDVs are not known, but are unrelated
o the number of polylactosaminoglycan chains in the
P-3P ectodomain. The finding that LDV-v is a double
enetic recombinant between LDV-vx and LDV-C indi-
ates that such recombinants can become selected in
ice under specific environmental conditions if they pos-ess a growth advantage under these conditions. Simi- uarly, genetic recombination could play an important role
n a potential spread of LDV to another host species.
MATERIALS AND METHODS
DV
The two neuropathogenic LDV quasispecies LDV-C
nd LDV-v and the two nonneuropathogenic LDV quasi-
pecies LDV-P and LDV-vx have previously been biolog-
cally cloned by repeated end-point dilutions in mice
Chen et al., 1997, 1998). LDV-C and LDV-v were isolated
nd cloned from LDV-C-BR- or LDV-VIR-infected, para-
yzed C58 mice, respectively, in which they were the
redominant quasispecies due to their productive infec-
ion of the anterior horn neurons of these mice (Chen et
l., 1997, 1998). LDV-vx was cloned from a BALB/c mouse
nfected with LDV-VIR and LDV-P from an FVB mouse
nfected with LDV-PLA in which they had become the
redominant quasispecies (Chen et al., 1998, 1999).
Stocks of these LDVs consisted of plasma harvested
rom groups of mice 1 day p.i. and contained 109–1010
D50/ml. Virus titers were determined by an end-point
ilution assay in FVB mice that is based on the plasma
DH elevation characteristic for LDV-infected mice
Plagemann et al., 1963; Chen and Plagemann, 1997).
VB mice (4–6 weeks of age) were provided by the
ransgenic Facilities of the University of Minnesota. To
btain plasma the mice were bled by the orbital method
sing heparinized Natelson blood collection tubes (Chen
nd Plagemann, 1997).
ifferential RT-PCR analyses and sequence analyses
Differential RT-PCR analyses were conducted as pre-
iously described (Chen et al., 1997, 1998; Chen and
lagemann, 1997) with slight modifications. In brief, total
NA was extracted from 4 ml of undiluted plasma of
nfected mice or from 20 ml of serial dilutions thereof
sing RNAzol and isopropanol precipitated with glyco-
en as coprecipitant. The RNA–glycogen pellet was
ashed with ethanol and dissolved in 11.5 ml of sterile
istilled water. A sample of RNA was supplemented with
andom hexanucleotides and oligo(dT), heated for 20 s in
boiling water bath, chilled in ice for 1 min, and supple-
ented with RNAsin, 53 RT buffer, dNTPs, sodium py-
ophosphate, and 5 units of AMV reverse transcriptase
Invitrogen, San Diego, CA) in a total volume of 21 ml.
fter 1.5 h of incubation at 42°C, an additional 5 units of
MV reverse transcriptase was added and the mixture
as further incubated at 42°C for 3 h. Alternatively, the
NA was reverse transcribed using Superscript II re-
erse transcriptase (Gibco BRL, Gaithersburg, MD) as
escribed previously (Chen and Plagemann, 1997). The
irst-strand products were treated with EDTA and NaOH
nd purified by passage through a self-made spin col-
mn containing Sepharose CL-6B (Chen et al., 1997;
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83RECOMBINATION OF LACTATE DEHYDROGENASE-ELEVATING VIRUShen and Plagemann, 1997). The purified first-strand
roducts were amplified in a 40-cycle (if not indicated
therwise) PCR program in a Perkin–Elmer Cetus DNA
hermal Cycle (Chen et al., 1997; Chen and Plagemann,
997) using the sense and antisense oligonucleotide
rimers indicated in individual experiments. The PCR
roducts were electrophoresed in agarose gels and pho-
ographed (Chen et al., 1997). Where indicated, the den-
ity of each gel band was determined with an Alpha
mager according to the procedure described by the
anufacturer (spot density measurement).
For sequence analysis, PCR products were excised
rom the gels, extracted from the excised gel segments,
nd purified by the use of a QIA quick gel extraction kit
Qiagen Inc., Chatsworth, CA) following the protocol sup-
lied by the manufacturer. The purified PCR products
ere cloned into the TA cloning vector pCR 2.1 vector
Invitrogen) according to the protocol provided by the
anufacturer. Plasmid DNA was extracted from appro-
riate clones of transformed bacteria and purified using
Qiagen Midi Prep kit and following the protocol pro-
ided by the manufacturer. The plasmid inserts were
equenced on both strands with the 373 automatic fluo-
escence DNA sequencer (Applied BioSystems Inc., Fos-
er City, CA) in the Microchemical Facilities of the Insti-
ute of Human Genetics, University of Minnesota. Se-
uence analyses were performed using the Molecular
iology Information Resource program EUGENE (Law-
ence and Goldman, 1988).
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